Diseases, Conditions, Syndromes

New compounds thwart multiple viruses, including coronavirus

According to a February 13 report from the World Health Organization, the Wuhan coronavirus has stricken more than 46,000 people and has caused over 1,300 deaths since the first cases in Wuhan, China, in December 2019. Now, ...

Medications

Major HIV drug requires vigilance, study says

A study lead by researchers at the Institute of HIV Research, Medical Faculty of UDE and University Hospital Essen reports a potential toxicity of integrase inhibitors. Integrase inhibitors (INSTI) are a preferred drug for ...

Cardiology

Natural antioxidant bilirubin may improve cardiovascular health

Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

Immunology

Biomarkers for irritable bowel syndrome

Little is still known about the exact causes of irritable bowel syndrome. An international team with significant involvement from the Technical University of Munich (TUM) has provided initial clues about the organic triggers ...

Alzheimer's disease & dementia

Structural analysis of relevant drug targets for Alzheimer's disease

Alzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant. In AD, the beta-amyloid precursor protein (β-APP) that ...

HIV & AIDS

A new way to nip AIDS in the bud

When new AIDS virus particles bud from an infected cell, an enzyme named protease activates to help the viruses mature and infect more cells. That's why modern AIDS drugs control the disease by inhibiting protease.

page 5 from 10